CLINICAL_TRIALS
trial_result
· 2017-03-13
Clinical Trial Update: Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer [Phase 3]
Summary
A Phase 3 clinical trial evaluated Vandetanib for efficacy and safety in patients with Differentiated thyroid cancer and has completed with results posted in 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Differentiated Thyroid Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-03-13